These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26559551)

  • 1. Nanostructured Delivery Systems: Augmenting the Delivery of Antiretroviral Drugs for Better Management of HIV/AIDS.
    Singh G; Pai RS; Mustafa S
    Crit Rev Ther Drug Carrier Syst; 2015; 32(6):503-33. PubMed ID: 26559551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances of resveratrol in nanostructured based delivery systems and in the management of HIV/AIDS.
    Singh G; Pai RS
    J Control Release; 2014 Nov; 194():178-88. PubMed ID: 25217813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanostructured drug delivery for better management of tuberculosis.
    Kaur IP; Singh H
    J Control Release; 2014 Jun; 184():36-50. PubMed ID: 24732260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in antiretroviral drug delivery using nanotechnology.
    Mallipeddi R; Rohan LC
    Int J Nanomedicine; 2010 Aug; 5():533-47. PubMed ID: 20957115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
    Nabi B; Rehman S; Baboota S; Ali J
    AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting parenteral combination antiretroviral loaded nano-drug delivery system to treat chronic HIV-1 infection: A humanized mouse model study.
    Mandal S; Kang G; Prathipati PK; Fan W; Li Q; Destache CJ
    Antiviral Res; 2018 Aug; 156():85-91. PubMed ID: 29885378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards nanomedicines for neuroAIDS.
    Sagar V; Pilakka-Kanthikeel S; Pottathil R; Saxena SK; Nair M
    Rev Med Virol; 2014 Mar; 24(2):103-24. PubMed ID: 24395761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage targeted nanocarrier delivery systems in HIV therapeutics.
    Khan T; Mayuresh Patkar M; Momin M; Omri A
    Expert Opin Drug Deliv; 2020 Jul; 17(7):903-918. PubMed ID: 32347124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-ART and NeuroAIDS.
    Das MK; Sarma A; Chakraborty T
    Drug Deliv Transl Res; 2016 Oct; 6(5):452-72. PubMed ID: 27137528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.
    Varghese NM; Senthil V; Saxena SK
    J Drug Target; 2018 Mar; 26(3):195-207. PubMed ID: 28866957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic Delivery of Anti-HIV Drug Nanoparticles.
    Nayak Y; Avadhani K; Mutalik S; Nayak UY
    Recent Pat Nanotechnol; 2016; 10(2):116-27. PubMed ID: 27502389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the use of novel drug delivery systems for antiretroviral drugs.
    Ojewole E; Mackraj I; Naidoo P; Govender T
    Eur J Pharm Biopharm; 2008 Nov; 70(3):697-710. PubMed ID: 18655830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dawn of antioxidants and immune modulators to stop HIV-progression and boost the immune system in HIV/AIDS patients: An updated comprehensive and critical review.
    Singh G; Pai RS
    Pharmacol Rep; 2015 Jun; 67(3):600-5. PubMed ID: 25933975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Past, Present, and Future Drug Delivery Systems for Antiretrovirals.
    Kirtane AR; Langer R; Traverso G
    J Pharm Sci; 2016 Dec; 105(12):3471-3482. PubMed ID: 27771050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Vault Nanoparticle Targeted Delivery of Antiretroviral Drugs to Inhibit Human Immunodeficiency Virus Type 1 Infection.
    Fulcher JA; Tamshen K; Wollenberg AL; Kickhoefer VA; Mrazek J; Elliott J; Ibarrondo FJ; Anton PA; Rome LH; Maynard HD; Deming T; Yang OO
    Bioconjug Chem; 2019 Aug; 30(8):2216-2227. PubMed ID: 31265254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
    Gupta U; Jain NK
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of polymeric nanoparticles in AIDS treatment and prevention.
    Khalil NM; Carraro E; Cótica LF; Mainardes RM
    Expert Opin Drug Deliv; 2011 Jan; 8(1):95-112. PubMed ID: 21143001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
    Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
    Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting strategies for delivery of anti-HIV drugs.
    Ramana LN; Anand AR; Sethuraman S; Krishnan UM
    J Control Release; 2014 Oct; 192():271-83. PubMed ID: 25119469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.